Przejdź do zawartości
Merck

Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction.

Reviews in gastroenterological disorders (2009-11-10)
Danial E Baker
ABSTRAKT

Constipation is a common problem associated with opiates and opioid compounds used for the treatment of pain and other medical conditions, and can influence patient quality of life. Methylnaltrexone appears effective in the therapy of opioid-induced constipation and will be useful for patients failing to respond to traditional laxative regimens.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Methylnaltrexone bromide, ≥97% (HPLC)